Cairo – Mubasher: The audited financial statements of Ibnsina Pharma on Sunday showed a 67.2% year-on-year growth in profits for 2017.
Net profit reached EGP 170.14 million last year, versus EGP 101.75 million a year earlier, the company said in a filing to the Egyptian Exchange (EGX).
Revenues rose to around EGP 9.82 billion in 2017, compared to EGP 7.4 billion in 2016.
The annual net profit has been audited, as compared with the previous financial indicators, came as a result of allocating EGP 22 million for some external entities, the pharmaceutical firm noted in a separated statement.
Given that the unaudited financial indicators of Ibnsina Pharma had shown a net profit of EGP 192.14 million for last year.
